+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06698796

Long-Term Safety and Effects of Dazukibart in Adults with Idiopathic Inflammatory Myopathies Including Dermatomyositis and Polymyositis

Led by Pfizer · Updated on 2026-08-25

211

Participants Needed

26

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how the study medicine dazukibart works in people with active idiopathic inflammatory myopathies, specifically dermatomyositis DM and polymyositis PM. These are conditions where muscles important for movement become inflamed, causing weakness in areas like hips, thighs, upper arms, and neck. DM can also cause a skin rash and these disorders may affect lung and heart function, impacting patients quality of life and daily functioning. Participants who previously took part in a study with dazukibart may enroll. Those receiving the medicine will get it through intravenous infusion every 4 weeks for about 12 months, totaling approximately 18 visits over 16 months. A safety follow-up period of about 4 months follows the last infusion. Some participants will not receive the study medicine but will take part in safety follow-up visits every 4 weeks, up to 4 visits. Throughout the study, participants will have regular assessments including monitoring for adverse events, laboratory tests, vital signs, electrocardiograms, lung function tests, and evaluations of muscle strength and disease activity. Patient-reported outcomes such as physical function, fatigue, and quality of life will also be collected. Safety follow-up continues after treatment ends, with total participation lasting about 16 months or up to 20 months for follow-up-only participants.

CONDITIONS

Brief Title

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

Research Team

P

Pfizer CT.gov Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here